1. Home
  2. RGEN vs KVYO Comparison

RGEN vs KVYO Comparison

Compare RGEN & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • KVYO
  • Stock Information
  • Founded
  • RGEN 1981
  • KVYO 2012
  • Country
  • RGEN United States
  • KVYO United States
  • Employees
  • RGEN N/A
  • KVYO N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • KVYO
  • Sector
  • RGEN Health Care
  • KVYO
  • Exchange
  • RGEN Nasdaq
  • KVYO Nasdaq
  • Market Cap
  • RGEN 8.0B
  • KVYO 9.8B
  • IPO Year
  • RGEN N/A
  • KVYO 2023
  • Fundamental
  • Price
  • RGEN $131.04
  • KVYO $31.43
  • Analyst Decision
  • RGEN Buy
  • KVYO Buy
  • Analyst Count
  • RGEN 11
  • KVYO 21
  • Target Price
  • RGEN $169.33
  • KVYO $43.05
  • AVG Volume (30 Days)
  • RGEN 677.5K
  • KVYO 1.5M
  • Earning Date
  • RGEN 07-29-2025
  • KVYO 08-06-2025
  • Dividend Yield
  • RGEN N/A
  • KVYO N/A
  • EPS Growth
  • RGEN N/A
  • KVYO N/A
  • EPS
  • RGEN N/A
  • KVYO N/A
  • Revenue
  • RGEN $650,429,000.00
  • KVYO $1,007,298,000.00
  • Revenue This Year
  • RGEN $13.93
  • KVYO $27.79
  • Revenue Next Year
  • RGEN $14.35
  • KVYO $20.95
  • P/E Ratio
  • RGEN N/A
  • KVYO N/A
  • Revenue Growth
  • RGEN 4.88
  • KVYO 33.95
  • 52 Week Low
  • RGEN $102.97
  • KVYO $22.12
  • 52 Week High
  • RGEN $182.52
  • KVYO $49.55
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 57.17
  • KVYO 37.84
  • Support Level
  • RGEN $123.34
  • KVYO $32.50
  • Resistance Level
  • RGEN $129.11
  • KVYO $34.29
  • Average True Range (ATR)
  • RGEN 4.31
  • KVYO 1.07
  • MACD
  • RGEN 1.06
  • KVYO -0.15
  • Stochastic Oscillator
  • RGEN 77.06
  • KVYO 11.76

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

Share on Social Networks: